Functional dyspepsia Digestive System Diseases of oesophagus, stomach and duodenum
Conditions
Interventions
Patients will be given either pure mastic gum in capsule form containing 350 mg or placebo capsules, twice daily. Patients will have treatment for three weeks. For safety reasons there will be a follo
Sponsors
Mastic Gum Producers Cooperative (Greece)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Rome II criteria for functional dyspepsia 2. Negative Helicobacter pylori status 3. Negative gastroduodenoscopy
Exclusion criteria
Exclusion criteria: 1. Primarily symptoms of Gastro-Oesaphageal Reflux Disease (GORD) 2. On prokinetic drugs 3. Suffering from Gastrointestinal (GI) malignancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Total symptom score changes, measured once at the end of treatment. 2. Global assessment of symptoms, measured once at the end of treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| Individual symptom changes, measured once, at the end of treatment. | — |
Countries
Greece
Outcome results
None listed